We developed and validated a six-gene prognostic risk model (ABCG1, HAVCR2, CD14, TGFA, KDF1, and KITLG) associated with macrophage differentiation for ccRCC patients. Here, TGFA is linked to nonpapillary renal cell carcinoma.